Potential of four marine-derived fungi extracts as anti-proliferative and cell death-inducing agents in seven human cancer cell lines

Objective:To evaluate the in vitro anticancer activity of crude ethyl acetate extracts of the culture of four marine-derived fungi Aspergillus similanensis KUFA 0013(E1),Neosartorya paulistemis KUFC 7897(E2),Neosartorya siamensis KUFA 0017(E4) and Talaromyces trachyspermus KUFC 0021(E3) on a panel of seven human cancer cell lines.Methods:Effects on cell proliferation,induction of DNA damage and cell death were assessed by MTT and clonogenic assays,comet assay and nuclear condensation assay,respectively.Results:The proliferation of HepG2,HCTl 16 and A375 cells decreased after incubation with the extracts E2 and E4.The anti-proliterative effect was confirmed by morphologic alterations and by clonogenic assay.Both extracts also induced cell death in HepG2 and HCT116 cells.Doxorubicin was used as a positive control and showed in vitro anticancer activity.Conclusions:This study demonstrated,for the first time,that extracts of Neosartorya paulistensis and Neosartorya siamensis have selective anti-proliferative and cell death activities in HepG2,HCT16 and A375 cells.The bioactivity of these extracts suggests a potential for biotechnological applications and substantiates that both should be further considered for the elucidation of the molecular targets and signal transduction pathways involved.

Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report

AIM： To evaluate the efficacy and safety of combined anti-vascular endothelial growth factor （VEGF） agents, oral glucocorticoid, and laser photocoagulation therapy for macular edema （ME） secondary to retinal vein occlusion （RVO）. METHODS： This study included 16 eyes of 16 patients with RVO-associated ME. Patients were initially treated with oral prednisone and an intravitreal anti-VEGF agent. Two weeks later, patients underwent standard laser photocoagulation. Best-corrected visual acuity （BCVA）, central retinal thickness （CRT）, and retinal vessel oxygenation were examined over 12mo. RESULTS： Patients received 1.43＋0.81 anti-VEGF injections. Mean baseline and 12-month IogMAR BCVA were 0.96±0.51 （20/178） and 0.31±0.88 （20/40）, respectively, in eyes with central retinal vein occlusion （CRVO） （P〈0.00）, and 1.02±0.45 （201209） and 0.60±0.49 （20/80）, respectively, in eyes with branch retinal vein occlusion （BRVO） （P〈0.00）. At 12mo, CRT had significantly decreased in eyes with CRVO （P〈0.00） and BRVO （P〈0.00）. Venous oxygen saturation had significantly increased in eyes with CRVO （P〈0.00） and BRVO （P〈0.00）. No examined parameters were significantly different between the 2 RVO groups. No serious adverse effects occurred. CONCLUSION： Anti-VEGF, glucocorticoid, and photocoagulation combination therapy improves visual outcome, prolongs therapeutic effect, and reduces the number of intravitreal injections in eyes with RVO- associated ME.

Clinical Study on Ganbi Decoction (肝痹汤) in Treating Antituberculotic Agent-Caused Liver Injury

Objective： To study the effect and mechanism of Ganbi decoction （GBD, 肝痹汤 ） in treating patients with antituberculotic agent caused liver injury （ATB-LI）. Methods： One hundred and twenty-eight patients with ATB-LI were randomly assigned to the treated group （ n = 66） and the control group （ n = 62） with the envelop method. Meanwhile, 60 healthy persons were selected as the healthy control group. The treated group was treated by GBD one dose every day with the constituents modified depending on patients＇ symp- toms, and the control group was treated with glucuronolactone tablets and inosine injection. One week was taken as one treatment course. The changes of clinical syndromes, physical signs, T-lymphycyte sub-groups and serum level of nitric oxide （NO） were observed before and after treatment and the recovery time of liver function was recorded. The outcome was compared with that in the healthy control group. Results： In the treated group, 28 patients （42.4%） were cured, 30 （45.5%） improved and 8 （ 12.1% ） ineffectively cured, the total effective rate being 87.9% （58/66）. In the control group, 17 patients （27.4%） were cured, 24 （38.7%） improved, and21 （33.9%）ineffectively cured, the total effective rate being 66.1% （41/62）. The total effective rate in the treated group was significantly higher than that in the control group （ P〈0. 05）. Liver function was improved in both groups, recovery time in the treated group was 12.0±7.0 days, which was significantly shorter than that in the control group （16.0±8.0 days）, showing significant difference between the two groups （ P〈0.05）. The levels of CD3, CD4 and CD8 were significantly higher and level of NO significantly lower in the two groups of patients than those in the healthy control group （ P〈0. 05）, but these parameters were improved more significantly in the treated group after treatment, when compared with those before treatment or with those in the control group, all showing significant difference （P〈0.05）. Conclusion： GBD could prevent ATB-LI, and its mechanism could be by way of reducing NO production induced by endotoxin of macrophage and stimulating the proliferation of T-lymphycyte to elevate immunity.

Effect of K1, K2 Anti-Bacterial Agents on Tobacco Ralstonia Solanacearum

The tobacco Ralstonia Solanacearum were both cultured on nutrient agar plates and inoculated in seedling stage of tobacco, then treated with K1 and K2, two anti-bacterial agents, at a serial con-centrations to study their inhibitory efficiency. The result indicated that K1 can inhibit R. Solanacearum growth entirely, at the concentration range from 1/50 to 1/5000. K2 can reach the same result at the concentration range from 1/50 to 1/50000. Compared with the control plates, K1, at the concentration 1/50000, had no significant differences, and the average number of colony per plate was 112-115. The immature tobacco shown wilt as soon as inoculated with R. Solanacearum, and recovered gradually after using K1, K2. The densities of microbial suspension, handled by K1, K2 within 10 hs, were both significantly lower than the controlled ones. The optical microscopy also shown that handled microbial body differed from the controlled, whose body was regular short, rod shape as opposed to the handled ones with irregular rod shape and damaged body. All the results indicated that K1 and K2 both had inhibitory effects on tobacco R. Solanacearum, and K2 was more efficient than K1.

Novel anti-diabetic agents in non-alcoholic fatty liver disease: a mini-review

BACKGROUND:Non-alcoholic fatty liver disease(NAFLD)encompasses a spectrum that ranges from simple steatosis to non-alcoholic steatohepatitis(NASH)and to cirrhosis.The recommended treatment for this disease includes measures that target obesity and insulin resistance.The present review summarizes the role of newer anti-diabetic agents in treatment of NAFLD.DATA SOURCES:PubMed,MEDLINE and Ovid databases were searched to identify human studies between January 1990and January 2013 using specified key words.Original studies that enrolled patients with a diagnosis of NAFLD or NASH and involved use of newer classes of anti-diabetic agents for a duration of at least 3 months were included.RESULTS:Out of the screened articles,four met eligibility criteria and were included in our review.The classes of newer anti-diabetic medications described were dipeptidyl peptidase IV inhibitors and glucagon-like peptide-1 analogues.CONCLUSIONS:Liraglutide and Exenatide showed improvement in transaminases as well as histology in patients with NASH.Sitagliptin showed improvement in transaminases but limited studies are there to access its effect on histology.Further studies are needed to support use of newer anti-diabetic medications in patients with NAFLD.

Challenges and opportunities of using stereotactic body radiotherapy with anti-angiogenesis agents in tumor therapy

Microvessels promote proliferation of tumor cells by delivering oxygen and nutrients, but rapid growth of tumors results in unmet demands for oxygen and nutrients, thereby creating a hypoxia microenvironment. Under hypoxic conditions, vascular endothelial cells（ECs） initiate the formation of immature and abnormal microvasculature. This results in leakage and tortuosity that facilitates tumor cell invasion, metastasis and resistance to cytotoxic treatment.Radiotherapy（RT） is a vital tumor treatment modality. Currently, more than 60% of patients with malignant tumors receive RT at certain points during their treatment. Hypoxia induced by abnormal microvessels can hamper the cytotoxic effect of ionizing radiation, particularly, stereotactic body radiotherapy（SBRT）. Anti-angiogenesis（AA） agents are known to reduce and renormalize microvessels in tumors, and hence alleviate hypoxia. The combination of AA agents with SBRT may have a synergistic role in inhibiting the growth of tumors. On the contrary, large doses of irradiation may affect tumor microvessels itself. In this review, we aim to clarify the relationship between SBRT and microvessel formation in tumors. In addition, we provide a retrospective analysis of the combination therapy involving SBRT and AA agents in preclinical and clinical practice to define its role in antitumor treatment.

Era of direct acting anti-viral agents for the treatment of hepatitis C

Hepatitis C infection is universal and the most common indication of liver transplantation in the United States. The period of less effective interferon therapy with intolerable side effects has gone. Now we have stepped into the era of direct acting anti-viral agents(DAAs) against hepatitis C virus. Treatment of hepatitis C is now extremely effective, tolerable and requires a short duration of intake of oral agents. Less monitoring is required with the current therapy and drug-drug interactions are less than the previous regimen. The current treatment options of chronic hepatitis C with various DAAs are discussed in this article.

Anti-angiogenic agents in metastatic colorectal cancer

Colorectal cancer(CRC) is a major public health concern being the third leading cause of cancer mortality in the United States. The availability of better therapeutic options has led to a decline in cancer mortality in these patients. Surgical resection should be considered in all stages of the disease. The use of conversion therapy has made surgery a potentially curative option even in patients with initially unresectable metastatic disease. In this review we discuss the role of various antiangiogenic agents in patients with metastatic CRC(m CRC). We describe the mechanism of action of these agents, and the rationale for their use in combination with chemotherapy. We also review important clinical studies that have evaluated the safety and efficacy of these agents in m CRC patients. Despite the discovery of several promising anti-angiogenic agents, m CRC remains an incurable disease with a median overall survival of just over 2 years in patients exposed to all available treatment regimens. Further insights into tumor biology and tumor microenvironment may help improve outcomes in these patients.

Toxicity Study of Anti-HABs Agents on Penaeus chinensis

In order to study the effect of anti-HABs agents on Penaeus chinensis, the toxicity experiments on clay, Ca(ClO)2, FeCl3, and AlCl3 to Penaeus chinensis are carried out. The results show that: (1) the clay isn't toxic to Penaeus chinensis; (2) Ca(ClO)2 has no toxicity to Penaeus chinensis at low levels, but has acute and chronic toxicity at high levels; (3) Penaeus chinensis can accumulate Fe and Al. The toxic effect needs further study.

Synthesis and Evaluation of Quinolino-Benzoxaboroles as Potential Antimicrobial Agents

Several quinolino-benzoxaborole derivatives have been prepared to start from aminobenzoxaboroles. These derivatives have been evaluated for their anti-cancer activity on human and murine cancer cell lines and based on their relative non-toxicity, these compounds were further evaluated for their antibacterial activity against E. coli, B. subtilis, and M. smegmatis. The synthesized compounds were also evaluated for antifungal activity in C. albicans and C. neoformans.

New innovation of moisturizers containing non-steroidal anti-inflammatory agents for atopic dermatitis

Atopic dermatitis is a chronic, relapsing and extremely pruritic eczematous disease which commonly affects children. The standard management consists of a combination of anti-inflammatory drugs in adjunctive with skin care management particular moisturizer application. A concern for the side effects associated with long term use of corticosteroids has also been considered. There has been an emerging interest in moisturizer containing non-steroidal anti-inflammatory agents such as herbal extracts, vitamins, mineral and lipids. The in vitro and the in vivo studies of each agent were reviewed. The clinical study on the efficacy of moisturizers containing these agents were also demonstrated including the author's studies and clinicalexperience. These moisturizers might be considered as an alternative treatment in acute flare of mild to moderate atopic dermatitis.

移动边缘计算下移动Agent的任务安全迁移策略

移动边缘计算中任务多在远离服务中心的边缘节点上执行,边缘节点的安全能力并不能得到保障,如何将任务迁移到安全可靠的边缘节点来执行是当前存在的一个问题。针对移动边缘计算下任务迁移中的安全风险问题,构建了适用于移动边缘计算环境的移动Agent安全风险计算模型,通过风险采集、风险处理和风险反馈综合评估边缘节点的抗风险值;并引入动态免疫算法,在任务计算和安全计算时间满足任务截止时间的前提下,实现任务迁移的安全能力最大化。仿真实验表明,相比于传统的任务迁移方案,该策略大大提高了移动边缘计算中任务迁移的抗风险能力,具有一定的鲁棒性。

Development of a SGJ-1 of Water-Based Anti-Wax Agent

The phenomenon of petroleum wax deposition is very common during oil well production. When the wax molecule condenses on the surface of the pipeline, it will hinder the exploitation of crude oil, reduce the recovery rate of crude oil, and may lead to the blockage of the pipeline when it is serious, so that the oil recovery work will stop. This phenomenon can be obviously changed by using wax cleaning agent. However, the low ignition point and toxicity of oil-based wax remover are not conducive to oil recovery. Therefore, a new water-based paraffin remover SGJ-1 was developed in this paper. The best formula is: wax dispersant 15%, wetting reversion agent 1%, sodium silicate 1%, alcohol cosolvent 8% and 75% water. Condensation point, wax dissolution rate and anti-wax performance of SGJ-1 water-based dewaxing and anti-waxing agent were tested by self-assembly testing device. The experimental results show that the condensation point of SGJ-1 is -34°C, the viscosity reduction effect is good under 35°C, and the wax dissolution rate is 0.0512 g/min, The highest wax prevention rate can reach 89.58% and the wax removal and wax prevention ability is excellent. Compared with other paraffin removers, SGJ-1 can also reduce the viscosity of crude oil, so it has a good development prospect.

复方红藤糖浆联合抗菌药物治疗盆腔炎性疾病的效果

目的探讨复方红藤糖浆联合抗菌药物治疗盆腔炎性疾病(PID)患者的效果及安全性。方法选取2018年1月至2021年12月安徽中医药大学第一附属医院妇科收治入院的60例PID患者为研究对象,按随机数字表法分为研究组和对照组,各30例。2组采用盐酸头孢替安联合奥硝唑氯化钠注射液静脉输注治疗,研究组同时予复方红藤糖浆口服,2组均治疗1周。比较2组患者临床疗效、疼痛视觉模拟评分(VAS)、盆腔痛客观体征(McCormack)评分、下腹疼痛、腰骶疼痛、带下异常、乏力中医症候积分、白细胞计数(WBC)、超敏C反应蛋白(hs-CRP)、白细胞介素(IL)-10、肿瘤坏死因子(TNF)-α。结果治疗后,研究组及对照组的总有效率分别为93.33%及73.33%;研究组总有效率高于对照组,差异有统计学意义(P<0.05)。与治疗前相比较,2组治疗后VAS评分、McCormack评分、下腹疼痛积分、腰骶疼痛积分、带下异常积分、乏力积分、WBC、hs-CRP、TNF-α降低,IL-10升高(P均<0.01)。与对照组治疗后相比较,研究组治疗后VAS评分、McCormack评分、下腹疼痛积分、腰骶疼痛积分、带下异常积分、乏力积分、WBC、hs-CRP、TNF-α降低,IL-10升高(P均<0.05)。结论复方红藤糖浆联合抗菌药物可改善湿热蕴结证盆腔炎患者临床症状,疗效明显。

FMEA联合PDCA在感染性休克1 h抗生素使用中的应用

目的探讨失效模式与效应分析(failure model and effect analysis,FMEA)联合PDCA管理工具在感染性休克患者1 h抗生素使用中的效果。方法选取河北医科大学第二医院收治的感染性休克患者177例及医护人员32例为研究对象。采用不同时间段分组,2组医护人员相同。以2022年1—6月的感染性休克患者87例及医护人员32名为对照组。以2022年7—12月90例感染性休克患者及32名医护人员为观察组。对照组采用常规管理。观察组采用FMEA联合PDCA管理。对比2组一般资料、风险优先数(risk priority number,RPN)值、1 h抗生素使用达标率、28 d病死率及医护人员合作满意度,分析影响1 h抗生素使用达标率的因素。结果患者一般资料、28 d病死率差异无统计学意义(P>0.05)。观察组感染性休克患者1 h抗生素使用达标率及医护合作满意度明显高于对照组,前5位失效模式的RPN值明显低于对照组,差异有统计学意义(P<0.05)。多因素分析结果显示,基础疾病(OR=0.585,95%CI:0.405~0.845,P<0.05)、抗生素使用级别(OR=0.272,95%CI:0.134~0.551,P<0.05)、患者家属教育程度(OR=2.484,95%CI:1.100~5.611,P<0.05)是影响1 h内抗生素使用达标率的独立危险因素。结论FMEA联合PDCA管理工具可规范感染性休克患者1 h抗生素使用流程,提高1 h抗生素使用达标率,加强医护合作。

高效液相色谱法测定洗发护发产品中18种防腐剂和去屑剂

建立高效液相色谱法(HPLC)同时测定不同基质化妆品中18种防腐剂和去屑剂组分的含量,并对50批市售洗发护发类化妆品进行质量分析。不同基质样品经前处理提取后,采用HPLC法分析,外标法定量。选取C18色谱柱(4.6 mm×250 mm,5μm),甲醇和磷酸二氢钠水溶液(pH调节至3.8)作为流动相,进行梯度洗脱,流速为1.0 mL/min,柱温30℃,选取二极管阵列检测器多波长分析。18种组分在色谱图中分离度良好,峰面积与质量浓度在0.4~600μg/mL范围内呈良好的线性关系(r>0.9983),检出浓度在0.4~10 mg/kg之间。多种组分平均回收率(n=6)为83.1%~110.4%,RSD为0.12%~7.6%,回收率良好;多种组分在24 h内保持稳定,RSD在0.15%~3.8%之间,稳定性良好。50批样品中检出9种成分,吡硫鎓锌、吡罗克酮乙醇胺盐、对氯间甲酚、氯咪巴唑、三氯生、水杨酸的含量分别为2100~6800,39~2900,130~370,24~1600,0.14~0.19,28~1900 mg/kg。苄氯酚、邻氨基苯酚、邻伞花烃-5-醇的含量检出但是含量小于定量限,无法准确定量。该方法经方法学验证,可同时测定化妆品中18种防腐剂和去屑剂组分的含量。

靶向胰岛素样生长因子系统抗肿瘤治疗的研究进展

胰岛素样生长因子(IGF)系统由配体、受体、结合蛋白组成。其中,配体主要有IGF-1、IGF-2和胰岛素,通过与特定的受体结合来发挥作用;涉及受体主要有Ⅰ型IGF受体(IGF-1R)、Ⅱ型IGF受体(IGF-2R)、胰岛素受体(IR)和IGF-1R与IR的杂合受体;此外,IGF系统还包括6种高亲和力IGF结合蛋白(IGFBP-1~6)。IGF系统不仅在调节人体重要生理过程(如细胞生长、分化以及新陈代谢等)方面具有关键作用,其各组分表达水平的变化还在肿瘤的发生发展中发挥重要作用。近些年的研究显示,靶向IGF系统的各个组分或其相关信号通路有助于阻断肿瘤的发生发展并对后续肿瘤治疗产生有益作用。本文综述了IGF系统的各组分及相关信号通路在肿瘤中的作用,以及目前靶向IGF系统各组分的抗肿瘤药物研究情况,并分析了靶向IGF系统在肿瘤治疗中遇到的问题,以期为靶向IGF系统的抗肿瘤药物研究提供思路。

四逆散药理作用及治疗内科疾病的临床应用研究

四逆散为《伤寒论》中记载的经典名方,至今约有1800年的历史,适用于少阴病症,临床多以手足不温、泄利下重、腹痛、脉弦等为辨证要点,具有透邪解郁、疏肝理脾之功效。中医认为该方剂治疗病症与阳衰阴盛有本质的区别,该证属外邪传经入里,气机为之郁遏,失于疏泄,阳气内郁不能达于四末所致,为阴中涵阳、惟气不宣通而致四肢逆冷。四逆散的应用十分广泛,几乎各系统疾病均可以该方剂为基础方进行辨证施治,尤其是现临床对四逆散的研究更加深入,其药理作用和应用领域也进一步被拓展,可广泛用于治疗胃肠肝胆疾病、精神类疾病、肿瘤疾病等。文章通过分析近年来四逆散的应用文献,总结其药理和治疗作用,为临床对四逆散有更加深入地了解,推动该方剂在临床的进一步开发应用。

解水锁剂的研究现状及展望

水锁效应是油气井生产的主要影响因素,尤其是对于低渗透储层影响更为显著。目前国内外学者在水锁损害机理、影响因素、解除方法、评价方法等方面做了大量研究,取得了较大进展。但是对于解水锁剂很少有系统性的归纳总结。因此,对现有的解水锁剂进行调研,通过了解各类解水锁剂的配方、性能评价方法和所取得的效果对后续解水锁剂的研究制备具有指导意义,在系统总结水锁的伤害机理和解水锁剂的作用机理的基础上,重点介绍了以改变润湿性、降低界面张力和恢复储层渗流能力为目标解除水锁伤害的酸液体系、表面活性剂体系和纳米体系,并对解水锁剂的评价方法进行总结归纳,提出了未来解水锁剂的发展趋势和研究重点。

替尔泊肽在肥胖人群中的应用

替尔泊肽作为首个用于慢性体重管理的葡萄糖依赖性促胰岛素多肽和胰高血糖素样肽-1双重受体激动剂,通过延缓胃排空、减少能量摄入实现减重,其治疗肥胖疗效显著,安全性高。替尔泊肽还能改善多种心血管代谢危险因素,如降低血糖、血压,改善血脂等,未来有望用于治疗肥胖伴心脑血管疾病、呼吸系统疾病、肝脏疾病等,应用前景广阔。本文对替尔泊肽的药动学、减重机制、临床应用及安全性等方面进行综述。